Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 27,376 | 17,052 | 12,533 | 4,319 | 9,223 |
| Cost of Goods | 4,175 | 3,586 | 3,641 | 1,726 | 459 |
| Gross Profit | 23,201 | 13,466 | 8,892 | 2,593 | 8,764 |
| Operating Expenses | 257,542 | 392,129 | 290,299 | 285,628 | 276,026 |
| Operating Income | -234,166 | -378,077 | -280,766 | -282,309 | -266,803 |
| Interest Expense | 8,575 | 8,446 | 8,335 | 2,612 | 0 |
| Other Income | 63,525 | 4,446 | -24,655 | -64,864 | -24,673 |
| Pre-tax Income | -179,216 | -382,077 | -313,756 | -349,785 | -291,476 |
| Income Tax | -3,793 | 2,819 | 2,165 | 3,999 | -163 |
| Net Income Continuous | -175,423 | -384,896 | -315,921 | -353,784 | -291,313 |
| Minority Interests | -27,245 | -32,882 | -24,331 | -21,975 | -21,251 |
| Net Income | $-33,617 | $-352,014 | $-291,590 | $-331,809 | $-270,062 |
| EPS Basic Total Ops | -0.03 | -0.49 | -0.42 | -0.48 | -0.40 |
| EPS Basic Continuous Ops | -0.23 | -0.54 | -0.45 | -0.51 | -0.43 |
| EPS Diluted Total Ops | -0.03 | -0.49 | -0.42 | -0.48 | -0.40 |
| EPS Diluted Continuous Ops | -0.23 | -0.54 | -0.45 | -0.51 | -0.43 |
| EBITDA(a) | $-228,213 | $-372,926 | $-275,691 | $-279,631 | $-265,097 |